T-Therapeutics secures $133M for cancer, autoimmune TCRs
Johnson & Johnson, Merck KGaA and Eli Lilly are joining Sanofi in backing a UK biotech working on T cell receptors for autoimmune conditions and cancer. The pharma companies or their corporate ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.